Pitt+Me - Pitt+Me

Welcome to the Eczema Studies Page

CURRENT STUDIES THAT MAY INTEREST YOU

A Study to Evaluate Risankizumab in Participants with Moderate to Severe Atopic Dermatitis

Have you been diagnosed with moderate-to-severe atopic dermatitis (eczema) for at least the past 2 years? If so, you may be eligible to participate in a study of an investigational drug called risankizumab in subjects with atopic dermatitis. Involves 11 visits over up to 65 weeks. Compensation is provided.

AGE:

18 and Up

DURATION: Up to 65 weeks
VISITS: 11 visits & 1 phone call

LOCATION: Falk Medical Building - Oakland

DRM-18-016: Eczema Study

Have you been diagnosed with eczema that is not responding to treatment? If so, you may be eligible to participate in a study to help researchers find out if an investigational drug called tradipitant is safe and effective at treating eczema. Eligible participants are 18-70 years old and have chronic itchy skin despite the use of steroids and antihistamines. Compensation provided.

AGE:

18 - 70

VISITS: 6 visits

LOCATION: Falk Medical Building - Oakland

MyPaTH Story Booth

Researchers are looking for volunteers to share a personal story about their experience as an individual facing a health problem or accessing the health system. Individuals could also share their experience as a caregiver for someone who is ill.

AGE:

18 and Up

VISITS: 1 visit lasting 20 minutes

LOCATION: Falk Medical Building (Oakland), or by phone

All of Us Pennsylvania Research Program

You may be able to change the future of medicine. The All of Us PA Research Program is enrolling adults 18 years of age or older. This may be your chance to improve how your children and your children’s children receive medical care.

AGE:

18 and Up

VISITS: one initial visit

LOCATION: Convenient locations near you including Altoona, Monroeville, North Hills, Oakland, Philadelphia, Shadyside, the South Hills and more!

RELATED RESEARCH AREAS:

Skin, Hair, and Nails